Mesenchymal stromal/stem cells in drug therapy: New perspective

Lauren S. Sherman, Maran Shaker, Veronica Mariotti, Pranela Rameshwar

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Abstract

Mesenchymal stromal/stem cells (MSC) have emerged as a class of cells suitable for cellular delivery of nanoparticles, drugs and micro-RNA cargo for targeted treatments such as tumor and other protective mechanisms. The special properties of MSC underscore the current use for various clinical applications. Examples of applications include but are not limited to regenerative medicine, immune disorders and anti-cancer therapies. In recent years, there has been intense research in modifying MSC to achieve targeted and efficient clinical outcomes. This review discusses effects of MSC in an inflammatory microenvironment and then explains how these properties could be important to the overall application of MSC in cell therapy. The article also advises caution in the application of these cells because of their role in tumorigenesis. The review stresses the use of MSC as vehicles for drug delivery and discusses the accompanying challenges, based on the influence of the microenvironment on MSC.

Original languageEnglish (US)
Pages (from-to)19-27
Number of pages9
JournalCytotherapy
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2017

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Cancer Research
  • Transplantation

Fingerprint

Dive into the research topics of 'Mesenchymal stromal/stem cells in drug therapy: New perspective'. Together they form a unique fingerprint.

Cite this